>

Veloxis Management Evaluation

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 40px;;'>VEL</div>
Inspection of Veloxis Pharmaceuticals management performance can provide insight into the corporation performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Veloxis Pharmaceuticals future performance. Check out World Market Map.
Symbol  VELO
Name  Veloxis Pharmaceuticals AS
TypeStock
Country   Denmark
Exchange  Copenhagen

Information on Veloxis Pharmaceuticals AS Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out.

FPH   
Purchased over 40 shares of
2 days ago
Traded for 28.15
ATM   
Purchased over 100 shares of
2 days ago
Traded for 16.43
RBD   
Purchased over 20 shares of
2 days ago
Traded for 7.3
ATM   
Purchased over 40 shares of
2 days ago
Traded for 16.43
FBU   
Purchased over 200 shares of
2 days ago
Traded for 3.37

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Veloxis Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (1.64) % which means that it has lost $1.64 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (26.39) % meaning that it generated substantial loss on money invested by shareholders.

Veloxis Pharmaceuticals Workforce Comparison

Veloxis Pharmaceuticals AS is rated first in number of employees category among related companies. The total workforce of Drug Manufacturers - Specialty & Generic industry is at this time estimated at about 237. Veloxis Pharmaceuticals totals roughly 58.0 in number of employees claiming about 24% of equities under Drug Manufacturers - Specialty & Generic industry.

Veloxis Pharmaceuticals Profit Margins

The company has Profit Margin (PM) of (2.46) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (4.22) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.04.
Check out World Market Map. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page